Imbalance of Plasminogen Activator Inhibitor-I/ Tissue Plasminogen Activator and Tissue Factor/Tissue Factor Pathway Inhibitor in Young Japanese Men with Myocardial Infarction
Masahiko Saigo(1), Satoshi Abe(1), Masakazu Ogawa(1), Tsuminori Yamashita(1), Sadatoshi Biro(1), Shinichi Minagoe, Ikuro Maruyama(2), Chuwa Tei(1)
(1)First Department of Internal Medicine, and (2)Department of Laboratory and Molecular Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Summary
To evaluate the association between haemostatic parameters and increasedrisk of myocardial infarction (MI) at a young age, we measuredfibrinogen, factor VII, antithrombin III, protein C, protein S, tissue factor(TF), free form tissue factor pathway inhibitor (TFPI), plasminogen,α2-antiplasmin, tissue plasminogen activator (tPA), plasminogen activatorinhibitor-I (PAI-I), and lipoprotein (a) in 140 young men withMI before age 45 and 150 age-matched healthy men. TF, TF/TFPI ratio,PAI-I, PAI-I/tPA ratio, plasminogen, and lipoprotein (a) in young MIpatients were all significantly higher than controls, while TFPI, antithrombinIII, and tPA were significantly lower (P <0.001 of each). Significantdeterminants of MI risk were PAI-I/tPA ratio (R2 = 0.300,P <0.001), TF/TFPI ratio (R2 = 0.049, P <0.001), antithrombin III (R2 =0.034, P <0.001), hyperlipidaemia (R2 = 0.019, P = 0.004), diabetes (R2 =0.014, P = 0.015), lipoprotein (a) (R2 = 0.012, P = 0.023), α2-antiplasmin(R2 = 0.014, P = 0.012), and protein C (R2 = 0.012, P = 0.018). We concludethat the imbalances of PAI-I/tPA and TF/TFPI are significantly associatedwith MI at a young age, perhaps mediated via impaired fibrinolytic activity.